C. Spalla
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
- Toxicology top 5%
Papers in
- Pharmacology 13
- Microbial Natural Products and Biosynthesis 9
- Fungal Biology and Applications 5
-
- Plant and fungal interactions 12
- Co-authors
- A. Grein (13 shared papers)Federico Arcamone (3 shared papers)Giuseppe Cassinelli (3 shared papers)P. Orezzi (2 shared papers)A. Minghetti (10 shared papers)M.L.P. Bianchi (1 shared paper)Nicoletta Crespi-Perellino (3 shared papers)G. FRANCESCHI (1 shared paper)
- Journals
- Cellular and Molecular Life Sciences (7 papers)Archives of Microbiology (3 papers)The Journal of Antibiotics (2 papers)Biotechnology and Bioengineering (2 papers)Mycopathologia (1 paper)
- Partner nations
- ItalySwitzerland
In The Last Decade
C. Spalla
30 papers receiving 802 citations
C. Spalla's Hit Papers
Peers
Comparison fields: 5 of 88
- Pharmacology 252
- Toxicology 39
- Microbiology 8
- Biotechnology 72
- Ecology, Evolution, Behavior and Systematics 151
Countries citing papers authored by C. Spalla
This map shows the geographic impact of C. Spalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Spalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Spalla more than expected).
Fields of papers citing papers by C. Spalla
This network shows the impact of papers produced by C. Spalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Spalla. The network helps show where C. Spalla may publish in the future.
Co-authors
The 16 scholars most cited alongside C. Spalla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius Hit paper breakdown → | 1969 | 477 |
| 2 | 2000 | 54 | |
| 3 | 1967 | 33 | |
| 4 | 1954 | 32 | |
| 5 | 1982 | 32 | |
| 6 | 1966 | 27 | |
| 7 | 1978 | 24 | |
| 8 | 1969 | 24 | |
| 9 | 1960 | 20 | |
| 10 | 1969 | 19 | |
| 11 | 1967 | 17 | |
| 12 | 1969 | 14 | |
| 13 | 1967 | 13 | |
| 14 | 1982 | 11 | |
| 15 | 1981 | 11 | |
| 16 | 1962 | 11 | |
| 17 | 1973 | 11 | |
| 18 | 1960 | 10 | |
| 19 | 1978 | 10 | |
| 20 | 1980 | 9 |
About C. Spalla
C. Spalla is a scholar working on Pharmacology, Ecology, Evolution, Behavior and Systematics, Plant Science, Organic Chemistry and Molecular Biology, having authored 32 papers that have together received 898 indexed citations. Recurring topics across this work include Plant and fungal interactions (12 papers), Microbial Natural Products and Biosynthesis (9 papers), Fungal Biology and Applications (5 papers), Chemical synthesis and alkaloids (5 papers), Actinomycetales infections and treatment (4 papers), Microbial Metabolism and Applications (3 papers), Infectious Diseases and Mycology (3 papers) and Porphyrin Metabolism and Disorders (3 papers). The work is most often cited by research in Pharmacology (252 citations), Toxicology (39 citations), Microbiology (8 citations), Biotechnology (72 citations) and Ecology, Evolution, Behavior and Systematics (151 citations). C. Spalla has collaborated with scholars based in Italy and Switzerland. Frequent co-authors include A. Grein, Federico Arcamone, Giuseppe Cassinelli, P. Orezzi, A. Minghetti, M.L.P. Bianchi, Nicoletta Crespi-Perellino, G. FRANCESCHI, F Arcamone and Silvana Penco. Their work appears in journals such as Cellular and Molecular Life Sciences, Archives of Microbiology, The Journal of Antibiotics, Biotechnology and Bioengineering and Mycopathologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.